Use of bisphosphonic acids for treating angiogenesis
OwnerTetsuji Okuno, Jonathan Green +1inventors
InventorsTetsuji Okuno, Jonathan Green, Jeanette Marjorie Wood
Life of this patent
Estimating the term…
Abstract
A method for the treatment of angiogenesis in a patient in need of such treatment, e.g. a tumour patient of a patient suffering from an inflammatory disease, which comprises administering, preferably via an intra-arterial route, an effective amount of a bisphosphonate, e.g. pamidronic acid or zoledronic acid or salts or hydrates thereof, to the patient.
Claims10
A method for the treatment of angiogenesis in a patient in need of such treatment which comprises administering an effective amount of a bisphosphonate to the patient.
Use of a bisphosphonate in the preparation of a medicament for the treatment of angiogenesis.
Use of a bisphosphonate to treat angiogenesis associated with diseases or pathological conditions in mammals.
A method for the embolic treatment of angiogenesis in a patient in need of such treatment which comprises administering an effective amount of a bisphosphonate to the patient;
- use of a bisphosphonate in the preparation of a medicament for the embolic treatment of angiogenesis;
- or
- use of a bisphosphonate as an angiogenesis reversing agent.
A method for the prophylactic or preventive treatment of angiogenesis in a patient in need of such treatment which comprises administering an effective amount of a bisphosphonate to the patient;
- use of a bisphosphonate in the preparation of a medicament for the prophylactic or preventative treatment of angiogenesis;
- or
- use of a bisphosphonate as an angiogenesis inhibiting agent.
A method for the embolic treatment of angiogenesis in a patient in need of such treatment which comprises intra-arterially administering an effective amount of a bisphosphonate to the patient;
- use of a bisphosphonate in the preparation of a medicament for the intra-arterial embolic treatment of angiogenesis;
- intra-arterial use of a bisphosphonate to treat or reverse angiogenesis associated with diseases or pathological conditions in mammals;
- and
- the intra-arterial use of a bisphosphonate as an angiogenesis reversing agent.
Dependencies are inferred from the claim text.